Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.SLSN · Entity 7041 | 10% owner | May 29, 2025 | June 02, 2025 |
| ULTRALIFE CORPULBI · Entity 6735 | Director · 10% owner | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date May 29, 2025 · Filed June 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Strandler, LLC | 30,373,270 |
Last balance in matching sequence
After 2025-05-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-05-29 · Purchase · Acquired 2,500,000 · Balance 26,184,270 F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 2 · 2025-05-29 · Purchase · Acquired 4,189,000 · Balance 30,373,270 F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Whitmore Holdings, LLC | 18,669,879 |
Last balance in matching sequence
After 2025-05-29 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2025-05-29 · Sale · Disposed 2,500,000 · Balance 22,858,879 F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 4 · 2025-05-29 · Sale · Disposed 4,189,000 · Balance 18,669,879 F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | Direct | 108,141 |
Reported balance
Holding disclosure · report date 2025-05-29 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 108,141 |
| Common StockSEC Table I · non-derivative | IndirectBy Grace Investments, LP | 675,515 |
Reported balance
Holding disclosure · report date 2025-05-29 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 675,515 F3: As manager of INV-GP, LLC, which is the General Partner of Grace Investments, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares.
F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
F3: As manager of INV-GP, LLC, which is the General Partner of Grace Investments, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares.
ULTRALIFE CORP
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Whitmore Holdings, LLC | 2,050,637 |
Last balance in matching sequence
After 2026-05-26 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-05-21 · Purchase · Acquired 32,876 · Balance 1,974,635 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.359. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 2 · 2026-05-22 · Purchase · Acquired 8,700 · Balance 1,983,335 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.2953 to $6.3995. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. Row 3 · 2026-05-26 · Purchase · Acquired 67,302 · Balance 2,050,637 F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.6399 to $6.9499. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares. |
| Common StockSEC Table I · non-derivative | Direct | 205,915 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 205,915 |
| Common StockSEC Table I · non-derivative | IndirectBy SUNRAY I, LLC | 4,452,283 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 4,452,283 F5: As manager of Sunray I, LLC, Bradford T. Whitmore is an indirect beneficial owner of 4,452,283 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.359. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F2: As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.2953 to $6.3995. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.6399 to $6.9499. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
F5: As manager of Sunray I, LLC, Bradford T. Whitmore is an indirect beneficial owner of 4,452,283 shares of Common Stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Clearside Biomedical, Inc.
Report date February 07, 2024 · Filed February 09, 2024
Section 16 reporting ended · disclosed 2024-02-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,495,034 |
Reported balance
After 2024-02-07 transaction · row 1
1 source rowRow 1 · 2024-02-07 · Purchase · Acquired 444,444 · Balance 4,495,034 |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.62 · Expires 2029-08-09 | Direct | 444,444 |
Reported balance
After 2024-02-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-07 · Purchase · Acquired 444,444 · Balance 444,444 |
| Common StockSEC Table I · non-derivative | Indirectby Grace Brothers, LP | 2,350,152 |
Reported balance
Holding disclosure · report date 2024-02-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,350,152 F1: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2021 Filed May 11, 2021 20:37 UTC | SOLESENCE, INC. NANX · Entity 7041 | ConversionCommon Stock | 10,095,555 | $0.20 | $2,019,111.00 |
DisclosureSEC source: 0000933430-21-000003 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,625,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the terms of the 2% Second Secured Convertible Note (the "Convertible Note"), the reporting person acquired: (i) 10,000,000 shares of Common Stock upon conversion of $2,000,000 in principal amount of the Convertible Note; and (ii) 95,555 shares of Common Stock upon the conversion of $19,111.11 of outstanding accrued and unpaid interest on the Convertible Note through May 7, 2021, the conversion exercise date. F2 · price: The principal and outstanding accrued and unpaid interest on the Convertible Note converted at a price of $.20 per share. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 14:49 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 350,750 | $2.85 | $999,988.25 |
DisclosureSEC source: 0000933430-21-000001 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,529,845 Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 15:30 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 51,195 | $1.95 | $99,896.80 |
DisclosureSEC source: 0000933430-20-000015 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179,095 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9403 to $1.9872. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| December 02, 2020 Filed Dec 2, 2020 21:22 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 53,900 | $1.95 | $105,051.10 |
DisclosureSEC source: 0000933430-20-000014 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,127,900 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.89 to $2.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| November 24, 2020 Filed Nov 24, 2020 21:46 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 62,000 | $1.65 | $102,045.80 |
DisclosureSEC source: 0000933430-20-000013 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,074,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.626 to $1.6899. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| November 16, 2020 Filed Nov 16, 2020 21:36 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 62,000 | $1.69 | $104,928.80 |
DisclosureSEC source: 0000933430-20-000012 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.73. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions on this Form 4. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 20:34 UTC | SOLESENCE, INC. NANX · Entity 7041 | OtherCommon Stock | 2,433,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000933430-20-000008 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Grace Brothers, LP Disclosed balance after: 0 F1 · price: Distribution to reporting person in his capacity as a partner of Grace Brothers, LP. F2 · ownership.direct: Bradford T. Whitmore is manager of BRO-GP, LLC, Grace Brothers, LP's General Partner. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 20:34 UTC | SOLESENCE, INC. NANX · Entity 7041 | OtherCommon Stock | 2,433,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000933430-20-000008 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,529,735 F1 · price: Distribution to reporting person in his capacity as a partner of Grace Brothers, LP. Read SEC document |
| August 13, 2020 Filed Aug 13, 2020 20:28 UTC Amendment | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 50,000 | $1.65 | $82,560.00 |
DisclosureSEC source: 0000933430-20-000007 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950,000 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.6899. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions on this Form 4. Read SEC document |
| August 13, 2020 Filed Aug 13, 2020 20:01 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 50,000 | $1.65 | $82,560.00 |
DisclosureSEC source: 0000933430-20-000006 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,950,000 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.6899. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions on this Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:28 UTC Amendment | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 300,000 | $1.63 | $489,120.00 |
DisclosureSEC source: 0000933430-20-000007 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.5866 to $1.71. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions on the Form 4. Read SEC document |
| August 12, 2020 Filed Aug 13, 2020 20:01 UTC | Clearside Biomedical, Inc. CLSD · Entity 82875 | PurchaseCommon Stock | 300,000 | $1.63 | $489,120.00 |
DisclosureSEC source: 0000933430-20-000006 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.5866 to $1.71. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:37 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,000 | $7.43 | $37,146.50 |
DisclosureSEC source: 0000933430-20-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,902 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.3431 to $7.50. The reporting person undertakes to provide, upon request of the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 11, 2020 Filed May 11, 2020 20:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,379 | $8.30 | $11,445.70 |
DisclosureSEC source: 0000933430-20-000004 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,902 Read SEC document |
| May 08, 2020 Filed May 11, 2020 20:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 3,800 | $8.18 | $31,076.02 |
DisclosureSEC source: 0000933430-20-000004 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,523 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.17 to $8.20. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:29 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 3,631 | $8.05 | $29,241.90 |
DisclosureSEC source: 0000933430-20-000004 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,723 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.09. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 06, 2020 Filed May 6, 2020 20:33 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,678 | $8.36 | $22,394.24 |
DisclosureSEC source: 0000933430-20-000003 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,092 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.34 to $8.37. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:33 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,978 | $8.38 | $24,964.87 |
DisclosureSEC source: 0000933430-20-000003 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,414 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.3001 to $8.42. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on the Form 4. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:33 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,534 | $7.64 | $42,290.27 |
DisclosureSEC source: 0000933430-20-000003 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,436 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50 to $7.94. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this From 4. Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 20:45 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,233 | $6.19 | $13,820.71 |
DisclosureSEC source: 0000933430-20-000002 · primary_doc.xml · nonDerivative · entry 4 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,902 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.17 to $6.19. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 20:45 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 30,092 | $5.37 | $161,512.79 |
DisclosureSEC source: 0000933430-20-000002 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,669 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.0286 to $5.70. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:45 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,703 | $5.23 | $8,914.01 |
DisclosureSEC source: 0000933430-20-000002 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,577 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.20 to $5.245. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:45 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 15,972 | $5.69 | $90,812.00 |
DisclosureSEC source: 0000933430-20-000002 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,874 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.65 to $5.7057. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 17:16 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 58,845 | $7.16 | $421,277.24 |
DisclosureSEC source: 0000933430-20-000001 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,902 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.08 to $7.29. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 17:16 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 41,155 | $7.35 | $302,443.98 |
DisclosureSEC source: 0000933430-20-000001 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,057 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.23 to $7.52. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 22:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | Purchase2% Second Secured Convertible Note · Derivative | Not disclosed | $2,000,000.00 Strike: $0.20 | $2,000,000.00 |
DisclosureSEC source: 0000933430-19-000007 · primary_doc.xml · derivative · entry 5 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 10,000,000 shares Expires 2024-05-15 F3 · derivative.exercise_date: The Convertible Notes will be exercisable if and when the Company has filed the Certificate Amendment pursuant to which the Company's authorized shares of Common Stock are increased by an amount sufficient to satisfy the conversion rights under the Convertible Note. Following such amendment, the Note is convertible at the discretion of the holder. If the certificate amendment is not filed by December 31, 2019, the Convertible Note is immediately due and payable. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:28 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 4,189,000 | $0.40 | $1,675,600.00 |
DisclosureSEC source: 0000933430-19-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,096,435 Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 21:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 2,500,000 | $0.40 | $1,000,000.00 |
DisclosureSEC source: 0000933430-17-000005 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,907,435 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 100 | $5.38 | $537.50 |
DisclosureSEC source: 0000933430-17-000004 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,902 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,834 | $5.40 | $31,503.60 |
DisclosureSEC source: 0000933430-17-000004 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,802 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 7,000 | $5.45 | $38,150.00 |
DisclosureSEC source: 0000933430-17-000004 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,968 Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 6,069 | $5.45 | $33,076.05 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 6 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,968 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 5,900 | $5.10 | $30,090.00 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 5 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,899 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 700 | $5.14 | $3,600.45 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 4 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,999 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 4,669 | $5.15 | $24,022.01 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,299 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 15,600 | $5.15 | $80,340.00 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,630 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:13 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 15,700 | $5.20 | $81,640.00 |
DisclosureSEC source: 0000933430-17-000003 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,030 Read SEC document |
| December 27, 2016 Filed Jan 11, 2017 21:21 UTC | ULTRALIFE CORP ULBI · Entity 6735 | OtherCommon Stock; $.10 par value | 3,272 | $0.00 | $0.00 |
DisclosureSEC source: 0000933430-17-000001 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by daughter Disclosed balance after: 3,272 Read SEC document |
| December 27, 2016 Filed Jan 11, 2017 21:39 UTC | SOLESENCE, INC. NANX · Entity 7041 | OtherCommon Stock | 51,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000933430-17-000002 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by daughter Disclosed balance after: 51,454 Read SEC document |
| November 15, 2016 Filed Nov 15, 2016 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 957 | $4.20 | $4,019.40 |
DisclosureSEC source: 0000933430-16-000012 · primary_doc.xml · nonDerivative · entry 6 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,330 Read SEC document |
| November 15, 2016 Filed Nov 15, 2016 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 11,450 | $4.25 | $48,662.50 |
DisclosureSEC source: 0000933430-16-000012 · primary_doc.xml · nonDerivative · entry 5 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,373 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,200 | $0.60 | $3,120.00 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 6 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,407,435 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,250 | $0.62 | $780.00 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 5 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,402,235 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,000 | $0.64 | $640.00 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 4 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400,985 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 10,000 | $0.64 | $6,439.00 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,399,985 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 10,000 | $0.65 | $6,450.00 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,389,985 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:50 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,228 | $0.65 | $3,398.20 |
DisclosureSEC source: 0000933430-16-000013 · primary_doc.xml · nonDerivative · entry 1 WHITMORE BRADFORD T · CIK 0000933430 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,379,985 F1 · balance_after: As a result of the transactions reported herein, Bradford T. Whitmore directly owns 10,407,435 shares of Common Stock. Bradford T. Whitmore is also an indirect beneficial owner, as General Partner of Grace Brothers, Ltd. of 2,433,300 shares, and as General Partner of Grace Investments, Ltd. of 601,410 shares. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 700 | $4.22 | $2,954.00 |
DisclosureSEC source: 0000933430-16-000012 · primary_doc.xml · nonDerivative · entry 4 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,923 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 14,100 | $4.25 | $59,854.50 |
DisclosureSEC source: 0000933430-16-000012 · primary_doc.xml · nonDerivative · entry 3 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,223 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:34 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 100 | $4.25 | $424.58 |
DisclosureSEC source: 0000933430-16-000012 · primary_doc.xml · nonDerivative · entry 2 WHITMORE BRADFORD T · CIK 0000933430 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,123 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.